CIPLA LINEZOLID linezolid 600 mg film-coated tablet bottle

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

linezolid, Quantity: 600 mg

Pieejams no:

Cipla Australia Pty Ltd

SNN (starptautisko nepatentēto nosaukumu):

Linezolid

Zāļu forma:

Tablet, film coated

Kompozīcija:

Excipient Ingredients: magnesium stearate; hyprolose; sodium starch glycollate type A; microcrystalline cellulose; maize starch; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3000

Ievadīšanas:

Oral

Vienības iepakojumā:

20, 100

Receptes veids:

(S4) Prescription Only Medicine

Ārstēšanas norādes:

CIPLA LINEZOLID is indicated for the treatment of suspected or proven infections due to Gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant Staphylococcus species and vancomycin resistant Enterococcus species.,CIPLA LINEZOLID is active against Gram-positive bacteria only. ,CIPLA LINEZOLID has no clinical activity against Gram-negative pathogens. Specific Gram-negative therapy is required if a concomitant Gram- negative pathogen is documented or suspected.

Produktu pārskats:

Visual Identification: White to off-white, oval shaped, biconvex, film-coated tablets, debossed on one side "CL".; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorizācija statuss:

Licence status A

Autorizācija datums:

2017-01-24